Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2022)
Top biotech stocks in 2022 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology

Zen Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership Technicals

Ticker	Company	Exchange	Industry	Market Cap	Price	1d %	EBITDA	P/E	D/E
INCY	INCYTE CORP	NASDAQ	Biotechnology	$15.49B	$69.64	0.20%	$694.45M	16.31x	0.30
EXEL	EXELIXIS INC	NASDAQ	Biotechnology	$5.02B	$15.60	-2.38%	$370.21M	18.35x	0.21
GMAB	GENMAB A	NASDAQ	Biotechnology	$24.14B	$36.72	2.74%	$815.98M	44.40x	0.12
UTHR	UNITED THERAPEUTICS CORP	NASDAQ	Biotechnology	$9.55B	$209.80	-1.06%	$874.60M	15.02x	0.28
MRNA	MODERNA INC	NASDAQ	Biotechnology	$48.96B	$125.15	-0.37%	$15.97B	3.58x	0.45
HALO	HALOZYME THERAPEUTICS INC	NASDAQ	Biotechnology	$5.76B	$41.82	0.38%	$256.86M	16.08x	5.08
VIR	VIR BIOTECHNOLOGY INC	NASDAQ	Biotechnology	$2.83B	$21.34	-4.09%	$1.36B	2.59x	0.34
CSBR	CHAMPIONS ONCOLOGY INC	NASDAQ	Biotechnology	$102.23M	$7.56	0.67%	$2.28M	252.00x	2.83
CPRX	CATALYST PHARMACEUTICALS INC	NASDAQ	Biotechnology	$1.28B	$12.47	-2.12%	$73.03M	23.53x	0.11
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	NASDAQ	Biotechnology	$2.85B	$48.12	-0.72%	$104.97M	49.10x	1.05
SESN	SESEN BIO INC	NASDAQ	Biotechnology	$99.73M	$0.50	4.17%	$35.40M	2.00x	0.24
CORT	CORCEPT THERAPEUTICS INC	NASDAQ	Biotechnology	$2.87B	$26.84	1.74%	$134.12M	26.31x	0.12
VRTX	VERTEX PHARMACEUTICALS INC	NASDAQ	Biotechnology	$76.59B	$298.63	-1.12%	$4.13B	23.95x	0.31
XOMA	XOMA CORP	NASDAQ	Biotechnology	$196.38M	$17.15	3.69%	$18.72M	19.94x	0.14
TECH	BIO-TECHNE CORP	NASDAQ	Biotechnology	$12.12B	$309.08	0.17%	$422.72M	44.60x	0.35
BNTX	BIONTECH SE	NASDAQ	Biotechnology	$33.42B	$137.53	0.25%	$17.28B	1.74x	0.26
REGN	REGENERON PHARMACEUTICALS INC	NASDAQ	Biotechnology	$79.78B	$731.86	-1.85%	$6.70B	13.71x	0.32
CDMO	AVID BIOSERVICES INC	NASDAQ	Biotechnology	$1.16B	$18.65	1.58%	$16.18M	9.28x	1.52
SIGA	SIGA TECHNOLOGIES INC	NASDAQ	Biotechnology	$687.16M	$9.41	-0.32%	$92.53M	9.80x	0.14
HUMA	HUMACYTE INC	NASDAQ	Biotechnology	$333.74M	$3.24	1.25%	$41.79M	1.31x	0.73
BLCM	BELLICUM PHARMACEUTICALS INC	NASDAQ	Biotechnology	$10.76M	$1.25	4.17%	-$7.76M	17.86x	0.32
AUPH	AURINIA PHARMACEUTICALS INC	NASDAQ	Biotechnology	$1.08B	$7.64	1.19%	-$152.92M	-6.59x	0.14
ETON	ETON PHARMACEUTICALS INC	NASDAQ	Biotechnology	$56.92M	$2.25	0.45%	-$9.39M	-4.79x	0.74
APVO	APTEVO THERAPEUTICS INC	NASDAQ	Biotechnology	$15.98M	$3.14	1.95%	$8.12M	2.36x	0.68
BGNE	BEIGENE LTD	NASDAQ	Biotechnology	$14.58B	$140.34	-2.72%	-$1.96B	-88.82x	0.39
SELB	SELECTA BIOSCIENCES INC	NASDAQ	Biotechnology	$267.25M	$1.75	1.16%	$53.13M	7.00x	1.10
SLGL	SOL-GEL TECHNOLOGIES LTD	NASDAQ	Biotechnology	$116.11M	$5.02	6.36%	$10.32M	11.95x	0.09
EFTR	EFFECTOR THERAPEUTICS INC	NASDAQ	Biotechnology	$26.32M	$0.64	2.42%	$26.06M	0.32x	1.22
LPCN	LIPOCINE INC	NASDAQ	Biotechnology	$42.31M	$0.48	-4.59%	$3.53M	11.95x	0.06
LQDA	LIQUIDIA CORP	NASDAQ	Biotechnology	$356.57M	$5.54	-0.72%	-$38.16M	-6.76x	0.36
DVAX	DYNAVAX TECHNOLOGIES CORP	NASDAQ	Biotechnology	$1.41B	$11.18	-1.93%	$248.32M	6.01x	1.42
GNFT	GENFIT SA	NASDAQ	Biotechnology	$189.30M	$3.80	-2.56%	$78.77M	-0.20x	1.37
CARA	CARA THERAPEUTICS INC	NASDAQ	Biotechnology	$520.60M	$9.69	-0.62%	-$64.74M	-7.69x	0.11
OCUP	OCUPHIRE PHARMA INC	NASDAQ	Biotechnology	$48.57M	$2.36	3.51%	-$22.05M	-2.29x	0.23
ABCM	ABCAM PLC	NASDAQ	Biotechnology	$3.67B	$16.03	-1.23%	$39.77M	93.20x	0.46
HCM	HUTCHMED (CHINA) LTD	NASDAQ	Biotechnology	$1.49B	$8.63	-7.20%	-$248.68M	-5.75x	0.43
ATNF	180 LIFE SCIENCES CORP	NASDAQ	Biotechnology	$24.62M	$0.65	-2.68%	$23.98M	0.87x	0.25
CELZ	CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC	NASDAQ	Biotechnology	$7.27M	$0.52	12.39%	-$4.86M	-0.14x	0.02
CLNN	CLENE INC	NASDAQ	Biotechnology	$114.30M	$1.80	-0.55%	$18.27M	6.92x	-80.12
AGEN	AGENUS INC	NASDAQ	Biotechnology	$792.86M	$2.80	18.14%	$87.05M	28.00x	129.55
HSTO	HISTOGEN INC	NASDAQ	Biotechnology	$3.55M	$1.42	-4.70%	-$10.92M	-0.29x	0.35
OPNT	OPIANT PHARMACEUTICALS INC	NASDAQ	Biotechnology	$56.55M	$10.95	-1.08%	-$17.29M	-2.87x	0.65
FUSN	FUSION PHARMACEUTICALS INC	NASDAQ	Biotechnology	$134.94M	$3.11	0.65%	-$74.35M	-1.78x	0.15
SPRC	SCISPARC LTD	NASDAQ	Biotechnology	$2.97M	$0.96	6.67%	-$1.74M	1.12x	0.22
MRUS	MERUS NV	NASDAQ	Biotechnology	$962.07M	$20.97	3.40%	-$52.56M	-16.26x	0.36
CLGN	COLLPLANT BIOTECHNOLOGIES LTD	NASDAQ	Biotechnology	$72.58M	$6.55	-3.29%	-$14.27M	-4.58x	0.12
RPTX	REPARE THERAPEUTICS INC	NASDAQ	Biotechnology	$557.77M	$13.30	-1.48%	-$129.10M	-4.05x	0.37
LOGC	LOGICBIO THERAPEUTICS INC	NASDAQ	Biotechnology	$66.91M	$2.03	0.25%	-$28.26M	-2.16x	1.27
LPTX	LEAP THERAPEUTICS INC	NASDAQ	Biotechnology	$88.13M	$0.89	-0.78%	-$49.28M	-1.93x	0.13
ZLAB	ZAI LAB LTD	NASDAQ	Biotechnology	$3.47B	$35.47	-4.32%	-$514.01M	-6.39x	0.17
BYSI	BEYONDSPRING INC	NASDAQ	Biotechnology	$40.87M	$1.05	9.38%	-$60.46M	-0.64x	2.07
RPRX	ROYALTY PHARMA PLC	NASDAQ	Biotechnology	$24.93B	$41.06	-1.61%	$651.43M	38.74x	0.70
XENE	XENON PHARMACEUTICALS INC	NASDAQ	Biotechnology	$2.38B	$38.30	3.15%	-$90.76M	-22.01x	0.03
PTGX	PROTAGONIST THERAPEUTICS INC	NASDAQ	Biotechnology	$424.58M	$8.65	0.35%	-$129.48M	-3.16x	0.16
QURE	UNIQURE NV	NASDAQ	Biotechnology	$944.39M	$20.21	0.50%	-$98.29M	-8.22x	0.44
MIRM	MIRUM PHARMACEUTICALS INC	NASDAQ	Biotechnology	$650.78M	$19.87	-3.87%	-$40.78M	-12.04x	1.69
LEXX	LEXARIA BIOSCIENCE CORP	NASDAQ	Biotechnology	$14.88M	$2.50	3.31%	-$7.01M	-2.00x	0.03
NBIX	NEUROCRINE BIOSCIENCES INC	NASDAQ	Biotechnology	$10.65B	$111.38	2.51%	$45.80M	856.77x	0.41
LMNL	LIMINAL BIOSCIENCES INC	NASDAQ	Biotechnology	$14.28M	$0.46	6.98%	$42.58M	0.36x	1.95
DBVT	DBV TECHNOLOGIES SA	NASDAQ	Biotechnology	$315.92M	$1.68	-2.89%	-$76.34M	-2.51x	0.17
BNOX	BIONOMICS LIMITED	NASDAQ	Biotechnology	$60.90M	$7.50	-2.28%	-$14.04M	-2.96x	0.15
EDIT	EDITAS MEDICINE INC	NASDAQ	Biotechnology	$876.40M	$12.75	1.76%	-$181.71M	-4.72x	0.25
SNDX	SYNDAX PHARMACEUTICALS INC	NASDAQ	Biotechnology	$1.48B	$26.24	6.11%	$3.27M	124.95x	0.12
GANX	GAIN THERAPEUTICS INC	NASDAQ	Biotechnology	$37.08M	$3.12	0.00%	-$16.19M	-2.29x	0.18
STTK	SHATTUCK LABS INC	NASDAQ	Biotechnology	$127.15M	$3.00	1.01%	-$59.36M	-2.07x	0.13
CLSD	CLEARSIDE BIOMEDICAL INC	NASDAQ	Biotechnology	$81.26M	$1.35	-1.46%	-$1.46M	-135.00x	0.22
BMRN	BIOMARIN PHARMACEUTICAL INC	NASDAQ	Biotechnology	$16.97B	$91.48	2.18%	$177.12M	315.45x	0.36
JANX	JANUX THERAPEUTICS INC	NASDAQ	Biotechnology	$561.62M	$13.48	-4.80%	-$54.20M	-10.53x	0.12
CGEM	CULLINAN ONCOLOGY INC	NASDAQ	Biotechnology	$592.96M	$13.00	4.84%	$157.82M	5.26x	0.10
ITOS	ITEOS THERAPEUTICS INC	NASDAQ	Biotechnology	$675.22M	$18.98	-1.40%	$425.14M	2.03x	0.28
RGNX	REGENXBIO INC	NASDAQ	Biotechnology	$999.48M	$23.12	1.49%	$140.95M	10.51x	0.51
DARE	DARE BIOSCIENCE INC	NASDAQ	Biotechnology	$84.82M	$1.00	1.01%	-$30.21M	-2.17x	0.56
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	NASDAQ	Biotechnology	$5.34B	$20.93	-1.83%	$380.04M	10.79x	3.06
EIGR	EIGER BIOPHARMACEUTICALS INC	NASDAQ	Biotechnology	$287.54M	$6.54	-6.84%	-$84.04M	-2.68x	0.59
SEER	SEER INC	NASDAQ	Biotechnology	$497.76M	$7.95	-0.25%	-$79.26M	-5.80x	0.09
ALEC	ALECTOR INC	NASDAQ	Biotechnology	$753.81M	$9.13	-1.19%	$46.62M	20.29x	2.08
MTEM	MOLECULAR TEMPLATES INC	NASDAQ	Biotechnology	$41.70M	$0.74	-7.50%	-$75.18M	0.48x	4.41
IMGN	IMMUNOGEN INC	NASDAQ	Biotechnology	$1.23B	$5.59	-1.24%	-$158.82M	-8.10x	0.69
INMB	INMUNE BIO INC	NASDAQ	Biotechnology	$118.44M	$6.60	-0.60%	-$32.87M	-3.53x	0.26
NHWK	NIGHTHAWK BIOSCIENCES INC	NYSEMKT	Biotechnology	$46.19M	$1.80	-0.55%	-$38.18M	-1.15x	0.38
PPBT	PURPLE BIOTECH LTD	NASDAQ	Biotechnology	$39.54M	$2.22	3.74%	$19.45M	N/A	0.11
ASMB	ASSEMBLY BIOSCIENCES INC	NASDAQ	Biotechnology	$82.34M	$1.70	0.59%	-$128.66M	-0.61x	0.16
AVEO	AVEO PHARMACEUTICALS INC	NASDAQ	Biotechnology	$303.57M	$8.77	-3.73%	-$31.41M	-8.51x	2.21
VACC	VACCITECH PLC	NASDAQ	Biotechnology	$123.19M	$3.31	0.91%	-$744.00k	-165.50x	0.12
DYAI	DYADIC INTERNATIONAL INC	NASDAQ	Biotechnology	$49.74M	$1.75	0.57%	-$11.71M	-4.17x	0.27
NOVN	NOVAN INC	NASDAQ	Biotechnology	$34.69M	$1.63	0.00%	-$35.02M	-0.84x	8.34
MREO	MEREO BIOPHARMA GROUP PLC	NASDAQ	Biotechnology	$137.89M	$0.94	-2.28%	$24.88M	8.98x	0.44
KMPH	KEMPHARM INC	NASDAQ	Biotechnology	$210.41M	$6.10	0.99%	-$30.38M	-2.26x	0.25
CGEN	COMPUGEN LTD	NASDAQ	Biotechnology	$59.77M	$0.69	0.00%	-$33.20M	-1.73x	0.22
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	NASDAQ	Biotechnology	$426.55M	$16.05	-0.43%	-$162.15M	-2.56x	0.97
VCYT	VERACYTE INC	NASDAQ	Biotechnology	$1.32B	$18.49	-0.75%	-$22.93M	-27.60x	0.08
CRSP	CRISPR THERAPEUTICS AG	NASDAQ	Biotechnology	$5.09B	$65.26	0.97%	-$601.68M	-7.89x	0.18
VCNX	VACCINEX INC	NASDAQ	Biotechnology	$26.67M	$0.63	2.12%	-$19.51M	-1.10x	0.15
AVIR	ATEA PHARMACEUTICALS INC	NASDAQ	Biotechnology	$472.08M	$5.67	-1.05%	$25.91M	31.50x	0.05
AADI	AADI BIOSCIENCE INC	NASDAQ	Biotechnology	$300.54M	$14.30	-0.14%	-$134.36M	-3.82x	0.18
SAGE	SAGE THERAPEUTICS INC	NASDAQ	Biotechnology	$2.53B	$42.66	3.12%	-$501.94M	-5.01x	0.07
SGEN	SEAGEN INC	NASDAQ	Biotechnology	$25.13B	$136.28	-0.43%	-$658.00M	-33.82x	0.24
TFFP	TFF PHARMACEUTICALS INC	NASDAQ	Biotechnology	$93.90M	$3.69	-8.44%	-$35.58M	-2.62x	0.17
ARGX	ARGENX SE	NASDAQ	Biotechnology	$20.31B	$368.77	-2.15%	-$923.94M	-20.98x	0.09
AGIO	AGIOS PHARMACEUTICALS INC	NASDAQ	Biotechnology	$1.58B	$28.83	-0.55%	-$352.89M	-5.13x	0.11

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Oct 2022?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the top biotech stock with a Zen Score of 74, which is 45 points higher than the biotech industry average of 29. It passed 24 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock return 5.8% over the past year, overperforming other biotech stocks by 45 percentage points.

Incyte has an average 1 year price target of $84.13, an upside of 20.8% from Incyte's current stock price of $69.64.

Incyte stock has a consensus Hold recommendation according to Wall Street analysts. Of the 9 analysts covering Incyte, 0% have issued a Strong Buy rating, 33.33% have issued a Buy, 55.56% have issued a hold, while 11.11% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Genmab A (NASDAQ:GMAB)

Genmab A (NASDAQ:GMAB) is the second best biotech stock with a Zen Score of 72, which is 43 points higher than the biotech industry average of 29. It passed 24 out of 33 due diligence checks and has strong fundamentals. Genmab A has seen its stock lose -14.55% over the past year, overperforming other biotech stocks by 24 percentage points.

Genmab A has an average 1 year price target of $37.15, an upside of 1.16% from Genmab A's current stock price of $36.72.

Genmab A stock has a consensus Sell recommendation according to Wall Street analysts. Of the 7 analysts covering Genmab A, 0% have issued a Strong Buy rating, 14.29% have issued a Buy, 57.14% have issued a hold, while 0% have issued a Sell rating, and 28.57% have issued a Strong Sell.

3. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the third best biotech stock with a Zen Score of 72, which is 43 points higher than the biotech industry average of 29. It passed 23 out of 33 due diligence checks and has strong fundamentals. Exelixis has seen its stock lose -25.36% over the past year, overperforming other biotech stocks by 14 percentage points.

Exelixis has an average 1 year price target of $30.43, an upside of 95.06% from Exelixis's current stock price of $15.60.

Exelixis stock has a consensus Buy recommendation according to Wall Street analysts. Of the 7 analysts covering Exelixis, 28.57% have issued a Strong Buy rating, 57.14% have issued a Buy, 14.29% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 4.78%, which is 3 percentage points higher than the biotech industry average of 1.68%.

Siga Technologies's dividend payout ratio of 46.9% indicates that its dividend yield is sustainable for the long-term.

2. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.8%, which is the same as the biotech industry average of 1.68%.

Royalty Pharma's dividend payout ratio of 67.9% indicates that its dividend yield is sustainable for the long-term.

3. Biontech Se (NASDAQ:BNTX)

Biontech Se (NASDAQ:BNTX) has an annual dividend yield of 1.53%, which is the same as the biotech industry average of 1.68%.

Biontech Se's dividend payout ratio of 2.7% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.06% in the last day, and up 4.17% over the last week. Kiromic Biopharma was the among the top gainers in the biotechnology industry, gaining 44.12% yesterday.

Kiromic BioPharma shares are trading higher after the company announced it received feedback from the FDA pursuant to its Type B Pre-IND meeting request regarding its Deltacel development strategy.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Vir Biotechnology (NASDAQ:VIR)

Vir Biotechnology (NASDAQ:VIR) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Vir Biotechnology has a valuation score of 100, which is 66 points higher than the biotech industry average of 34. It passed 7 out of 7 valuation due diligence checks.

Vir Biotechnology's stock has dropped -36.36% in the past year. It has overperformed other stocks in the biotech industry by 3 percentage points.

2. Molecular Templates (NASDAQ:MTEM)

Molecular Templates (NASDAQ:MTEM) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Molecular Templates has a valuation score of 100, which is 66 points higher than the biotech industry average of 34. It passed 7 out of 7 valuation due diligence checks.

Molecular Templates's stock has dropped -88.54% in the past year. It has underperformed other stocks in the biotech industry by -50 percentage points.

3. Moderna (NASDAQ:MRNA)

Moderna (NASDAQ:MRNA) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Moderna has a valuation score of 86, which is 52 points higher than the biotech industry average of 34. It passed 6 out of 7 valuation due diligence checks.

Moderna's stock has dropped -58.62% in the past year. It has underperformed other stocks in the biotech industry by -20 percentage points.

Are biotech stocks a good buy now?

47.87% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 95.91% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 16.62x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.